Treatment with the glucagon receptor antagonist LY2409021 increases ambulatory blood pressure in patients with type 2 diabetes
This loss of natural cushioning can interfere with mobility, limiting physical activity and affecting quality of life
CrossRef Association Between Metabolically Associated Steatotic Liver Disease (MASLD) and Cardiovascular Risk Scores in Urban Adults FARIS HUSSAIN, KELVIN KANAYO NWABUEZE, FATIMA IJAZ, SONIA OUTALEB, MAHMUDUL HASAN NAHID, SYED ABID, MARIAM SALEEM, KHANT NYI ZAYA, SAIFULLAH SYED, HUMAIRA JANANTH, MANAHIL ZARIEF Juntendo Medical Journal .2026
How Does GLP-1 Compare to Other Weight Loss Medications
The European Food Safety Authority (EFSA) reviewed BHT and concluded it is safe at regulated levels in food
3Based on patient weight of 50 kg 14